CivaDerm(TM) Surface Therapy Pilot Study

Completed · Early Phase 1

Conditions studied: Basal Cell Carcinoma, Squamous Cell Carcinoma of the Skin

In brief

This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell and squamous cell carcinoma patients by providing conformal radiation therapy to the surface of the skin.

Key facts

Study ID

NCT04480645

Run by

CivaTech Oncology

People needed

10

Starts

2024-05-01

Expected to finish

2026-01-30

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subject signed informed consent
• Confirmed superficial or nodular basal cell or squamous cell carcinoma
• Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
• >5 mm of residual tumor
• tumors < 3 cm
• Capable of complying with Patient Release Instructions

You may not qualify if…

• Is unable or unwilling to comply with the protocol requirements
• Pregnant or breast feeding
• Metastases

Where it is running

• CivaDerm Oncology PLLC — Morrisville, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.